Regimens. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Antilymphocyte Serum

Organisms4

HIV-1 Helicobacter pylori Transplantation Chimera HIV

Diseases39

HIV Infections Recurrence Neutropenia Lymphoma, Non-Hodgkin Nausea Vomiting Lung Neoplasms Breast Neoplasms Neoplasm Metastasis Leukopenia Graft vs Host Disease Hodgkin Disease Neoplasm Recurrence, Local Neoplasms Disease Progression Hematologic Diseases Thrombocytopenia Colorectal Neoplasms Acute Disease Adenocarcinoma Hematologic Neoplasms Multiple Myeloma Helicobacter Infections Precursor Cell Lymphoblastic Leukemia-Lymphoma Carcinoma, Non-Small-Cell Lung Disease Models, Animal Fever Tuberculosis, Pulmonary Leukemia Ovarian Neoplasms Carcinoma, Small Cell Tuberculosis Tuberculosis, Multidrug-Resistant Leukemia, Myeloid, Acute Stomatitis Body Weight Lymphoma Stomach Neoplasms Brain Neoplasms

Chemicals and Drugs127

Cyclophosphamide Vincristine Doxorubicin Fluorouracil Anti-HIV Agents Cisplatin Etoposide Prednisone Anti-Bacterial Agents Methotrexate Antineoplastic Agents Deoxycytidine Leucovorin Drug Combinations Immunosuppressive Agents Vinblastine Cytarabine Busulfan Benzoxazines Paclitaxel Vidarabine Antitubercular Agents Organoplatinum Compounds HIV Protease Inhibitors Taxoids Ifosfamide Bleomycin Rifampin Ritonavir Carboplatin Reverse Transcriptase Inhibitors Epirubicin Nevirapine Amoxicillin Camptothecin Antineoplastic Agents, Alkylating Melphalan Pyrazinamide Isoniazid Clarithromycin Antimetabolites, Antineoplastic Procarbazine Dacarbazine Stavudine Antibodies, Monoclonal, Humanized Metronidazole Organophosphonates Antibodies, Monoclonal Lopinavir Bismuth Antineoplastic Agents, Phytogenic Dexamethasone Antibiotics, Antitubercular Oxazines Mitoxantrone Ethambutol Anti-Retroviral Agents Granulocyte Colony-Stimulating Factor Prednisolone Anti-Ulcer Agents Antibodies, Monoclonal, Murine-Derived Lamivudine Antimalarials Anthracyclines Carmustine Anti-Infective Agents Mycophenolic Acid Zidovudine Dideoxynucleosides Ofloxacin Tacrolimus Omeprazole Pyrimidinones Cyclosporine Myeloablative Agonists Artemisinins Aza Compounds Quinolines Azithromycin Antiemetics Adenine Doxycycline Mechlorethamine Antilymphocyte Serum Thiotepa Didanosine Fluorenes Ondansetron Nelfinavir Idarubicin Gentamicins Levofloxacin Vindesine Penicillins 2-Pyridinylmethylsulfinylbenzimidazoles Tegafur Ranitidine Mesna Lomustine Amikacin Antiviral Agents Recombinant Proteins Pyrazines Asparaginase Rifabutin Interferon-alpha Insulin, Long-Acting Diarylquinolines Boronic Acids Methylprednisolone Mitomycin Topotecan Penicillin G Procaine Saquinavir Furazolidone Antibiotics, Antineoplastic Hypoglycemic Agents Mefloquine RNA, Viral Vancomycin Tinidazole Thalidomide Lansoprazole Primaquine Daunorubicin Indinavir Ciprofloxacin

Analytical, Diagnostic and Therapeutic Techniques and Equipment66

Drug Administration Schedule Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Drug Therapy, Combination Combined Modality Therapy Survival Analysis Administration, Oral Infusions, Intravenous Disease-Free Survival Transplantation Conditioning Remission Induction Salvage Therapy Survival Rate Retrospective Studies Prospective Studies Treatment Failure Antiretroviral Therapy, Highly Active Follow-Up Studies Hematopoietic Stem Cell Transplantation Clinical Trials as Topic Double-Blind Method Viral Load Transplantation, Autologous Whole-Body Irradiation Transplantation, Homologous Area Under Curve Prognosis Bone Marrow Transplantation Chemotherapy, Adjuvant Neoplasm Staging CD4 Lymphocyte Count Injections, Intravenous Drug Evaluation Randomized Controlled Trials as Topic Pilot Projects Random Allocation Immunization, Secondary Injections, Intramuscular Microbial Sensitivity Tests Kaplan-Meier Estimate Cohort Studies Neoadjuvant Therapy Cross-Over Studies Risk Factors Maximum Tolerated Dose Injections, Subcutaneous Kidney Transplantation Feasibility Studies Drug Monitoring Clinical Trials, Phase II as Topic Drug Dosage Calculations Disease Models, Animal Clinical Trials, Phase III as Topic Immunosuppression Drug Substitution Multivariate Analysis Hematopoietic Stem Cell Mobilization Colony Count, Microbial Actuarial Analysis Peripheral Blood Stem Cell Transplantation Antibiotic Prophylaxis Body Weight Stem Cell Transplantation Retreatment Infusions, Parenteral Premedication

Psychiatry and Psychology2

Patient Compliance Medication Adherence

Phenomena and Processes16

Dose-Response Relationship, Drug Time Factors Viral Load Area Under Curve CD4 Lymphocyte Count Drug Resistance, Viral Graft Survival Half-Life Graft Rejection Maximum Tolerated Dose Drug Interactions Drug Resistance, Neoplasm Drug Synergism Pregnancy Drug Resistance, Multiple, Viral Body Weight

Information Science1

Health Care30

Treatment Outcome Survival Analysis Disease-Free Survival Survival Rate Retrospective Studies Prospective Studies Treatment Failure Follow-Up Studies Clinical Trials as Topic Patient Compliance Double-Blind Method Area Under Curve Randomized Controlled Trials as Topic Pilot Projects Random Allocation Medication Adherence Kaplan-Meier Estimate Cohort Studies Cross-Over Studies Risk Factors Feasibility Studies Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Drug Substitution Multivariate Analysis Actuarial Analysis Age Factors Cost-Benefit Analysis Infectious Disease Transmission, Vertical Safety

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Information Science Health Care

Drug Administration Schedule Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Drug Therapy, Combination Cyclophosphamide Vincristine Doxorubicin Fluorouracil Anti-HIV Agents Cisplatin Combined Modality Therapy Etoposide Dose-Response Relationship, Drug Survival Analysis Administration, Oral Infusions, Intravenous Time Factors HIV Infections Disease-Free Survival Prednisone Transplantation Conditioning Anti-Bacterial Agents Methotrexate Remission Induction Salvage Therapy Antineoplastic Agents Survival Rate Deoxycytidine Leucovorin Retrospective Studies Drug Combinations Prospective Studies Treatment Failure Immunosuppressive Agents Vinblastine Cytarabine Recurrence Antiretroviral Therapy, Highly Active Busulfan Follow-Up Studies Benzoxazines Hematopoietic Stem Cell Transplantation Paclitaxel Clinical Trials as Topic Patient Compliance Vidarabine Antitubercular Agents Organoplatinum Compounds HIV Protease Inhibitors Taxoids Ifosfamide Double-Blind Method Neutropenia Bleomycin Rifampin Ritonavir Carboplatin Viral Load Lymphoma, Non-Hodgkin Transplantation, Autologous Whole-Body Irradiation Reverse Transcriptase Inhibitors Epirubicin Transplantation, Homologous Nevirapine Nausea Area Under Curve Amoxicillin Camptothecin Vomiting Antineoplastic Agents, Alkylating Prognosis Bone Marrow Transplantation Melphalan Pyrazinamide Chemotherapy, Adjuvant Isoniazid HIV-1 Neoplasm Staging CD4 Lymphocyte Count Drug Resistance, Viral Lung Neoplasms Injections, Intravenous Drug Evaluation Clarithromycin Antimetabolites, Antineoplastic Randomized Controlled Trials as Topic Procarbazine Breast Neoplasms Dacarbazine Stavudine Antibodies, Monoclonal, Humanized Metronidazole Pilot Projects Organophosphonates Random Allocation Antibodies, Monoclonal Immunization, Secondary Lopinavir Bismuth

No FAQ available that match "regimens"